Donald E Staunton

Title: The Innovations of Donald E. Staunton

Introduction

Donald E. Staunton is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 7 patents to his name, Staunton's work has the potential to impact various medical applications.

Latest Patents

One of Staunton's latest patents focuses on humanized PAI-1 antibodies. This application relates to compositions of humanized anti-PAI-1 antibodies and antigen-binding fragments that convert PAI-1 to its latent form. The patent details antibodies that have modifications in at least one amino acid residue of the framework regions of the variable heavy chain, the variable light chain, or both. Additionally, it describes antibodies that bind and neutralize PAI-1 by converting it to its latent form or increasing proteolytic cleavage. The use of these humanized antibodies is aimed at the detection, diagnosis, or treatment of diseases associated with PAI-1.

Career Highlights

Throughout his career, Staunton has worked with several prominent companies, including Icos Corporation and Cisthera, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and antibody development.

Collaborations

Staunton has collaborated with notable colleagues such as Maximiliano Vasquez and Edith Salot Harris. These partnerships have likely enhanced his research and development efforts in the biotechnology sector.

Conclusion

Donald E. Staunton's innovative work in the field of humanized antibodies showcases his significant contributions to biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for various diseases.